Kimberly Marselas

Kimberly Marselas is senior editor of McKnight’s Long-Term Care News. She joined the staff in 2021 after working as a contributor for eight years. A proud journalism graduate of the University of Maryland, Kim started her career as a daily newspaper reporter and has always been drawn to stories involving children and seniors (and food). She is a fast and dedicated reader and a slow and somewhat less-dedicated half marathoner. She lives in central Pennsylvania with her husband and three children.

Most recent articles by Kimberly Marselas

Print News

Jodi Eyigor is finding her distinct voice

Kimberly Marselas

January 31, 2021

Jodi Eyigor, Director of Nursing Home Quality and Policy, LeadingAge

News

OnPointe CEO: Pandemic should be catalyst for payment changes, shedding ‘wrong strategy’

Kimberly Marselas

January 29, 2021

Some look at the ongoing COVID-19 crisis and question how they can make their buildings safer. Eric Tanner, CEO of transitional and skilled care specialist OnPointe, sees the crisis as a launching point for irrevocable, industry-wide change.

News

‘Strap on your seat belts,’ as post-acute experts forecast opportunities amid threats of week-old Biden administration

Kimberly Marselas

January 27, 2021

Long-term care providers wary of extra scrutiny should also be prepared for new opportunities in an administration that will likely expand insurance coverage and embrace innovative care models that could reshape the referral process. That was one of several takeaways from Wednesday’s NIC Leadership huddle featuring post-acute care policy experts Dan Mendelson, founder of Avalere…

News

New Five-Star ratings ding providers for infection control lapses; overall performance stagnant

Kimberly Marselas

January 27, 2021

Despite more than 12,000 infection control-related citations given during the COVID-19 pandemic, most U.S. nursing homes didn’t see their ratings change much in updated Five-Star guidance published Wednesday. An analysis by Formation Healthcare Group found the prevalence of citations has not changed drastically during the pandemic, with the average health tags cited per facility dropping…

News

Lawsuit challenges nursing home liability protections for non-COVID death

Kimberly Marselas

January 27, 2021

Survivors of a former North Carolina nursing home resident are suing the facility where she died in what could be a litmus test for the patchwork of liability protections granted to healthcare providers across the country. North Carolina is one of nearly 30 states that gave nursing homes legal immunity to shield them from lawsuits…

News

Also in the News for Thursday, Jan. 28

January 27, 2021

Fewer SNFs banked value-based incentives in pandemic-affected 2020 … Second monoclonal antibody formulation, this one with injectable option, shows promise as COVID-19 preventative … Police: Nursing home employee exploited electronic system to order Oxy refills — for herself … Johnson & Johnson says it can produce up to 100 million single-dose coronavirus vaccines by June…

About Us

2021 McKnight’s Long-Term Care News Editorial Calendar

January 26, 2021

Nurse applying vaccine on patient's arm wearing face mask

News

Experts urge providers: Start planning now to ensure extra shots of COVID-19 vaccines

Kimberly Marselas

January 21, 2021

Early this month, AMFM Nursing & Rehabilitation Centers celebrated the completion of second-round COVID-19 vaccinations at all 19 of its buildings — before many had even offered a first round and nearly two months ahead of the target a national provider organization has set for all U.S. facilities to finish both rounds.

Clinical Daily News, News

A potential ‘miracle’? Feds push monoclonal antibody treatments toward SNFs

Kimberly Marselas

January 19, 2021

COVID-19 monoclonal antibodies are now widely available for use by skilled nursing facilities — and early results show promise, according to long-term care pharmacy leaders.

Image of Gen. Gus Perna, COO, Operation Warp Speed

Clinical Daily News

As a much-anticipated vaccine rolls out, others face obstacles

Kimberly Marselas

December 13, 2020

Even as the U.S. government authorized Pfizer’s coronavirus vaccine for emergency use late last week, drugmakers around the world acknowledged new challenges in developing other immunizing drugs that would bolster supplies.

Next post in Clinical Daily News